patients with this type of tumour arrive in neurosurgical units as emergencies in deep stupor even though they may have had symptoms suggestive of a cerebral tumour for several months. Lumbar puncture offers little help in the diagnosis of cerebral tumours yet it is still often performed unwisely and even in the absence of papilleedema may provoke a catastrophic deterioration in the patient's condition.
Failure is often more impressive than success. None the less, although the results of treatment of intracranial gliomata may be uncertain in any particular case, with improving methods of investigation and management and an optimistic attitude many patients may survive to lead useful lives perhaps for several years. REFERENCES Cushing H (1932) 
Radiotherapy of Gliomata: Clinical and Biological Factors
Many facets of the morphology of tumours arising from neuroglia have been exposed since Bailey and Cushing's classical histogenetic studies, in which they showed that the longest survivals were associated with the more highly differentiated tumours. The Mayo Clinic classification of Kernohan et al. (1949) based on the idea that gliomata arise from a pre-existing adult astrocyte, oligodendrocyte or ependymal cellhas further emphasized the importance of cellular differentiation. Their scheme, recognizing a gradual transition in the case of astrocytomata from the well-differentiated grade 1 to the highly malignant grade 4 (synonymous with glioblastoma multiforme), has been increasingly accepted and is adopted in this paper. Its main defect is the assumption that each glioma takes origin from a single cell. Bailey (1948) had already emphasized that most tumours are made up of several types of cell which reproduce but crudely the normal embryonic elements; the use of Bailey and Cushing's classical ten groups depended on certain cellular types dominating the appearance. This concept of the multipotential tumour received further support from the experimental work of Zimmerman (1955) , showing that under the influence of a chemical carcinogen many different adult and morphologically distinct glial cells begin to proliferate almost simultaneously to form a glioma. In view of this heterogeneity, a small biopsy may give but limited information as to the nature of the whole tumour (Fig 1) . As radiotherapy of gliomata has been conducted increasingly on the results of needle biopsies, circumspection is needed in analysing the subsequent progress of small numbers of cases in relation to a specific histological label.
More important, however, from the prognostic viewpoint is the question of tumour 'de-differentiation' which is implicit in Kernohan's concept of tumours arising from adult neuroglia. As is well known, most cerebral astrocytomata show regions of more primitive cell structure ranging from scattered foci to diffuse areas recognizable macroscopically. Thus Sherer (1940a) described only 5 out of 125 cases as microscopically benign, while Russell & Rubinstein (1959) found microscopic de-differentiation to be absent in only 10 out of 243 intracranial gliomata. The tumour may be extremely anaplastic from the start, as commonly happens in glioblastomata: or, with the continued development of a well-differentiated tumour, areas of anaplasia may be revealed, so that the pathologist refers to the picture of a 'dedifferentiated astrocytoma'. It is clearly important to recognize that if a patient is treated for a grade 2 astrocytoma (and indexed according to the biopsy) and the subsequent autopsy, after perhaps three years, reveals most of the tumour to be of grade 4 (glioblastoma), each label taken alone would be quite inadequate to analyse the effects of treatment.
There is a nuance attached to the concept of tumour 'de-differentiation' that differentiated astrocytomatous cells and even adult astrocytes are becoming progressively less differentiated with the development of the tumour. This may be so in those uncommon highly-differentiated tumours which develop over many years as the carcinogenic stimulus may continue to act on the neuroglia. It is, however, not mere tautology to stress that the de-differentiation usually applies to the static proportions of the tumour as a whole and not to a previously recognized adult cell. It was a neurologist, Sherrington (1942) who described growth as a 'dynamic of living form'. In considering the development of gliomata and their behaviour under the influence ofirradiation, it may therefore be helpful to translate a static picture of form into a dynamic process of cell proliferation. Within a typical glioma we have a mixed population of cells of varying degrees of differentiation. While neurones are irreplaceable, the microglia is in a 'steady state' in which cell-proliferation balances cell-destruction in proportion to the rare reparative needs of the tissue (Adrian & Walker 1962) . Each type of astrocytomatous cell, however, has its own innate capacity for proliferation with its own rate of replication, and this is reproduced throughout the development of that particular cell-strain from an original clone. Each tumour contains these cells in different proportions so that it is made up in effect of a number of cell-populations each having its own growth characteristics, which result in their being present in different initial and final proportions. So the progressive 'de-differentiation' of an astrocytoma and the increased tempo of the later stages of its development may be explained as the progressive overgrowth of the more anaplastic elements having short replication periods. This is illustrated in an elementary form in Fig 2, where the problem is over simplified almost to the point of caricature by considering only binary division, simple proportions of anaplastic and well differentiated cells and a high ratio of rates of proliferation. If we points, which may well coincide with surgical biopsies at A and B and an eventual autopsy C, we find very different static pictures corresponding with increasing histological gradings. The final apparently rapid growth-rate and the ultimate histological appearance are thus not due to late 'de-differentiation' but to the continuing overgrowth of a small anaplastic population over its originally more numerous neighbours. Radiotherapy has as its ideal the suppression of the reproductive capacity of all the neoplastic cells; short of this the number inhibited by a certain dose is related to the proportion of cells in each population (Oliver & Lajtha 1961) and from the radiobiological point of view, the heterogeneity of gliomata becomes important. Here, as elsewhere, we need to know much more of the relative replication times of normal and neoplastic cells, and for gliomata in man this information is elusive.
The main clinical indication of growth rate is the patient's history, but the estimate of length of symptoms may be highly erroneous. Only the final onset of hydrocephalus may be accurately dated and, as this is due mainly to mechanical factors, it has little relevance to the earlier period of growth. The limitations and lack of correlation in individual cases have been considered elsewhere (Jones 1960) . Nevertheless, in a series of 25 cases of supratentorial astrocytomata the symptomduration period varied from three to eighty-four months in grade 1 tumours, from three to 276 months in grade 2, but only from four to thirty months in grade 3; and in a series of 30 cases of glioblastoma multiforme only 3 patients had histories of more than twenty-four months and these (72, 108, and 120 months) were related to tumours de-differentiating. The history of a glioma involves pre-and post-treatment periods. Penman & Smith (1954) regarded the survival period after onset as a more significant feature than either of its component parts. In reporting results it is important that symptom-duration be included in the data as an indicator of the biological nature of a series, but the time before and after treatment should be separately stated to avoid the inaccuracy of history assessment vitiating any comparisons.
In the treatment of neoplastic disease surgeryand irradiation have greatest value when the parent tissue is expendable: surgery when tissue may be excised, radiotherapy when it is capable of regeneration. All malignant tumours, like all living tissues, are in varying degrees radiosensitive, and the factor of clinical importance is the relative sensitivity of the tumour and its environment. The radiosensitivity of normal nervous tissue therefore becomes of paramount importance in the radiotherapy of gliomata. Stated radiobiologically, the balance lies between suppression of reproductive capacity of the tumour and the production of somatic injury in the host. Somatic radiation injury is, however, often the cumulative end-result of impaired reproductive capacity in normal tissues, and in the case of the nervous system it must be remembered that cellular turnover occurs only in the blood-vessels and microglia and not in the neurones. The limited tolerance of brain-tissue to irradiation is well recognized, thanks to studies such as those of O' Connell & Brunschwig (1937) , of Pennybacker & Russell (1948) and of Lindgren (1958) . Clinically the untoward sequelh are shown by progressive neurological deficit originating in a volume of brain previously irradiated, and occurring without evidence of raised intracranial pressure some three months to five years after the irradiation.
Pathologically, the changes are often rendered difficult to recognize by the predominance of persistent tumour, and also by the irradiation changes themselves simulating the appearance of glioma. These lesions consist mainly of areas of necrosis, himorrhage, demyelination and gliosis, with a predilection for subcortical white matter. The question of whether the primary injury is neuronal and glial, or purely vascular, has often been discussed. Pennybacker & Russell were impressed by the vascular changes in their own material and concluded that massive focal necrosis and gliosis of the brain followed fibrinoid necrosis, thrombosis and collagenous thickening of the perforating vessels; the subsequent experimental study (Russell et al. 1949 ) supported this contention. Much experimental work on the -radiosensitivity of the brain has recently been carried out with an orientation towards the wider problems of nuclear energy rather than to those of radiotherapy (cf. Symposium: Effects of lonising Radiation on the Nervous System, IAEA 1962). Single massive doses have often been used, and these reveal the hypothalamus (and particularly the paraventricular and supra-optic nuclei) as the most radioresponsive structure (Clemente & Holst 1954 , Arnold, Bailey, Harvey, Haas & Laughlin 1954 . Although all nervous elements are sequentially affected by high intensity irradia--tion, the earliest changes affect the blood brain barrier (BBB) mechanism as shown by increase in vascular permeability which allows fluid to pass into the astrocytes. Scholz et al. (1962) found, by Cajal impregnation, and Hager et al. (1962) by electron microscopy, that either vessel walls or astrocytes or both were initially damaged. The fundamental lesion seems to lie in the vasculoastrocytic unit, 'the most radio-vulnerable component of the CNS' (Haymaker 1962) . The delayed neurological effects are considered to be primarily of vascular origin, the important factor being the number of mitotic cycles which radiation-injured endothelial cells are capable of undergoing (Zeman 1961). Once the cyclic process fails the BBB mechanism breaks down, and the different types of lesion have been correlated by Haymaker with the time and degree of breakdown of the vasculo-astroglial unit. The ease with which the paraventricular and supra-optic nuclei in the hypothalamus are subject to late radionecrosis is thus related to their rich capillary bed. The predilection of the lesions for the white matter has also been explained by Berg & Lindgren (1958) on a vascular basis: the vascularity is much more sparse than in the grey matter so that a lesion of equivalent size becomes more deleterious in its effect. But preoccupation with the vascular effects of irradiation should not detract from a consideration of the effects on neuroglia, which from inhibition of its reproductive capacity becomes unable to repair the initial damage, so that a chain-reaction of injury is set up. Effects on oligodendroglial reproduction are similarly important in relation to progressive demyelination. The evidence is against a direct neuronal effect of radiation (on the postnatal brain, and within the clinical range of dosage); but the vascular and neuroglial effects cannot be considered in isolation and emphasize the importance of reproductive inhibition, and the vasculo-astrocytic unit, in the pathogenesis of delayed radiation injury.
The threshold single dose for brain injury has been stated as 1,000 r, but considerable speciesdifferences exist in the nature and degree of response, and this dose cannot be extrapolated to prolonged irradiation. In man we are more concerned with the effects of repeated fractions, and the important guides are those of Boden (1950) , who stated the irradiation tolerance of small volumes of brain stem to be not greater than 4,500r in seventeen days, and Lindgren (1958) , who found the minimal dose to produce necrosis was between 4,500 and 5,000 r in thirty days when delivered through medium-sized fields. Both these findings are for ortho-voltage radiations (170-250 V), and because of the different linear energy transfer of megavoltage radiations, the figures will be subject to an appropriate small increase depending on the diminished relative biological efficiency.
An important limiting factor in radiotherapy is the volume irradiated: the greater the volume, the lower the tolerance to irradiation. Much of the tolerance of larger volumes depends on the integrity of the blood supply, and for most somatic tissues the dose-volume relationship may now be forecast within clinical limits. A warning is indicated, when extrapolating such information directly to the nervous system, because of the absence of collateral circulation within a cerebral hemisphere. As the pathology of late radionecrosis depends essentially on vasculo-astroglial effects, the radiation tolerance of increasing volumes of the brain cannot be deduced simply from connective-tissue experience, and the problem must be approached with circumspection, especially as many small lesions may be clinically silent.
Modem methods of radiotherapy can usually ensure adequate and uniform irradiation of the tumour, and the physicaj properties of megavoltage radiation from radiocobalt units and linear accelerators can be turned to good advantage in sparing skin reaction, minimizing the dose to normal brain and avoiding the shielding effect of bone (Jones 1960) . At St Bartholomew's Hospital, 257 cases of intracranial glioma have been treated by megavoltage radiation in the last twenty-five years. From 1937 to 1959 one million volt X-rays were employed, the usual tumour dose being 4,000 r in twenty-eight days. Since then telecobalt radiation and 15 MeV X-rays have been used to give doses of 4,500 to 5,000 rads in thirty-five days for astrocytoma, or up to 5,500 rads in forty-two days at 15 MeV for glioblastoma.
The most important factor in determining the technique of radiotherapy for a given level of dosage is the volume and anatomical distribution of the tumour. Depending on the histology and growth pattern, the volume irradiated varies widely. For the radiosensitive and metastasizing medulloblastoma, simultaneous irradiation of the whole cerebrospinal axis to an adequate dose can be tolerated even in children, and has resulted in 50 % of patients surviving three years (Paterson & Farr 1953 , Richmond 1953 . Preliminary surgical excision of the main tumour-mass is desirable not only to confirm the diagnosis and provide decompression, but also because small cellaggregates are more radiosensitive than large tumours. At the other extreme, tumours of the posterior third ventricle, usually pinealomata or ependymomata, require high radiation dosage (5,500-6,000 rads in forty-two days) which can be localized to the tumour by megavoltage methods, so sparing the normal brain. Relief of hydrocephalus by ventriculocisternostomy (Torkildsen's operation) renders subsequent radiotherapy much easier, and this policy has produced a median survival of sixty months in 6 cases, 2 of which now survive at fifteen and sixteen years. The commoner astrocytomata are essentially invasive and usually much more extensive than the macroscopic appearance suggests. Sherer (1940b) showed that in the cerebrum many fibrillary tumours are diffuse gliomatous processes, so that the volume irradiated may occupy half or even two-thirds of a hemisphere. The anaplastic A lox 9cm 1%100% 10 Y10 c r tumours seek a route of escape from the confines of the space-occupying lesion, and this is often provided by the corpus callosum. In the case of glioblastoma multiforme, Bull & Rovit (1957) showed that one-quarter of their cases had bilateral involvement of the brain, and this type of 'butterfly distribution' of glioblastoma is sufficiently common in the frontotemporal region to demand an appropriate technique of irradiation. Before the growth patterns of gliomata and the limitations of clinical and radiological localization were appreciated, many tumours were irradiated by over-localized techniques; but a nihilistic reaction is now sometimes apparent, in which the topographic problems are shortcircuited by resorting to whole-brain irradiation as a routine. This policy of despair is clearly undesirable in view of the limited radiosensitivity of most gliomata, and the lessened'radiation tolerance of the brain as the volume increases. By megavoltagemethods, uniformirradiationat moderately high dosage can be delivered to relatively large volumes while sparing the remainder of the brain (Fig 3) .
In analysing the results of such procedures in 102 cases of supratentorial glioma (Jones 1960) it became apparent that the important factors governing prognosis were'the age of the patient and the anaplasia of the tumour. Penman & Smith (1954) pointed out that in their series 'youth and a comparatively long survival period were strongly associated'. In our series the age effect was most marked in glioblastoma, where the median survival for patients under 35 was twenty-nine months compared with fourteen months for the older age group. Not only did the younger patients live longer, but they responded better symptomatically to irradiation. While the age effect vitiated the comparison of different dosage groups in glioblastoma, the effect was less marked in the other astrocytomata. Clearly the age composition of the series, like the symptom-duration, should be stated when comparing results. On comparing the symptom-duration and survivals in 25 cases of astrocytoma, it was difficult to demonstrate evidence ofresponse to irradiation in grade 1 (median survival 23 months, average 44 9 months); some grade 2 tumours responded (median survival 35'5, average 39-3 months); while the majority of cases of grade 3 tumours benefited quite obviously (average survival 46-4 months). The response of grade 3 tumours to megavoltage therapy in the dosage range 4,000-5,000 rads in thirty-five days has been obvious clinically: about half the cases returned to economic work or domestic duties, the response was independent of age, and it appears that the favourable feature is a degree of cell anaplasia devoid of the sinister changes of glioblastoma multiforme.
The statistical results of radiotherapy in any series of glioblastoma multiforme (grade 4 astrocytoma) are frankly disappointing. Only 3 of 30 cases (Jones 1960) survived for three years, and none for five years. The variables ofcase selection, age composition, and proportion of de-differentiated tumours makes comparison of the different series invidious; but there is little to choose between the results of most methods of radiotherapy. There is no doubt, however, that clinical improvement with tumour regression can be achieved in many cases, from radiation dosage within the tolerance of normal brain; but the response is generally transient. In the 30 cases cited, headache was relieved in 15, and hemiparesis improved in 3 out of 7 cases, the most satisfactory responses being in young patients. Nevertheless, regrowth of tumour is the rule, even when the radiation dosage is at the limit of brain tolerance.
Two main reasons may be advanced for the poor long-term results. The high intrinsic malignancy of the tumours is evident from the cellular pleomorphism, often with bizarre mitoses and giant-cell formation. More important radiobiologically are the widespread degenerative and vascular changes characteristic of glioblastoma. The areas of degeneration and necrosis may vary from microscopic foci to large cavities recognizable on needle biopsy. The vascular changes consist not only of thromboses, with multiple areas of tumour-infarction and haemorrhage, but also the development of new vessels having small calibre, thin walls, endothelial proliferations and often glomerulus-like tufts; this vascular hyperplasia may be of such intensity as to resemble an angioma. The proliferations may also extend into normal tissue, an effectanalogous with the 'stromal reaction' to epithelial neoplasms. While Davis et al. (1949) found the prognosis to be somewhat better in cases showing angioproliferative changes, as far as tumour restraint is concerned the stromal reaction is clearly inefficient. From the radiotherapeutic viewpoint the vascular changes act as a distinct disadvantage. The radiosensitivity of tumours depends upon the oxygen tension. It has been established, notably by Gray et al. (1953) , that cells which are normally oxygenated can be sterilized by about one-third of the radiation dosage necessary to produce the same degree of damage if the cells were completely anoxic.
Anoxic cells may therefore survive the largest dosage of radiation permissible in practice and, by their regrowth, lead to recurrence of tumour. In fact, the proportion of cells which may survive a single exposure of 4,500 rads is ten million times smaller if the cells are aerobic than if they are anaerobic at the time of irradiation (Gray 1961) .
The curability of a tumour depends critically on the oxygen tension of partially anoxic cells, even though they may be numerically less than 1 % of the neoplastic cell population. The distribution of oxygen tension within a tumour becomes therefore of prime importance. The vascular proliferations of glioblastomata are affected early in the course of radiotherapy. While the immediate effect may be necrosis of a proportion of tumour cells and apparent benefit from the 'indirect effect' of radiation, the ultimate result may be quite different; for although tumour infarction and necrosis may follow the thromboses, the residual tumour becomes less radiosensitive.
More important is the effect of the pathological glioblastomatous circulation on the tumour as a whole. Angiographic evidence indicates the rate of blood flow to be diminished in the pathological vessels, and a concomitantly low oxygen tension in surrounding tumour is likely to result from this stasis, protecting the cells from the effects of radiation. The main obstacles to success in the radiotherapy of glioblastomata are therefore no longer physical and technical: and they are clearly not only the limited inherent radiosensitivity compared with normal brain, but the sequential effects which occur in the pathology of the tumour itself.
Attempts may be made to overcome these difficulties in the following ways: Ancillary surgery: If the anoxic and radioresistent tumour cells can be surgically removed without impairing the blood supply of the remainder, the effective radiosensitivity will be enhanced. The limitations of surgical excision relate mainly to the periphery of the tumour, while the necrotic and degenerative parts are often central. Spontaneous tumour necrosis, elicited on needle biopsy, augurs lack ofradiosensitivity, and it would be reasonable in such cases to carry out macroscopic surgical excision as a prelude to irradiation, unless the neurological deficit would be too great, or the tumour is deeply placed or extends into the other hemisphere. Hyperoxygenation: The oxygen tension around anoxic cells may be increased by breathing additional oxygen under high pressure. Churchill-Davidson et al. (1957) demonstrated an enhanced effect of radiation on some human tumours at oxygen pressures of three atmospheres, and treated a number of cases of glioma. Satisfactory initial response was recorded in most cases, but 6 of 7 patients died within five to forty-five months (Churchill-Davidson 1961 . The disadvantages are the need for repeated high-pressure-chamber oxygen administration under general anesthesia, and the consequent limitation of the radiotherapeutic regime to fewer fractions (and therefore larger individual doses) than usual. Hypothermia: Reduction of temperature decreases the consumption of oxygen but increases the amount dissolved in tissues. Walsh in 1959 therefore suggested irradiation of glioblastomata under hypothermia in the hope of increasing tumour radiosensitivity. In a trial in 14 cases (Bloch et al. 1961) it was shown that cerebral tissues themselves become more radiosensitive under hypothermia; and experiments in mice (Bloom & Dawson 1961 ) also supported the view that mild hypothermia increases tissue radiosensitivity. Anoxia: The converse of oxygenation, rendering the normal tissue completely anoxic while the tumour retains some oxygenation, is even more potent in radiosensitization. In small-animal experiments it can increase the relative radiosensitivity of the tumour by a factor of 2-8 (Lindop & Rotblat 1961) . In large animals the method is limited by the untoward cerebral and cardiac effects of anoxia appearing before the skeletal tissues have sufficiently lost their oxygen. The brain, however, is unique in that the partial pressure of oxygen falls to 4 mm in less than 30 seconds (Nunn 1962; Lindop 1963, personal communication) ; the high dose rates from a linear accelerator enable the radiation dose to be delivered in a few seconds, and the anoxia and radiation treatment could be completed well within a period of tolerance of three minutes for cerebral anoxia. The difficulty would be in obtaining uniform irradiation and in avoiding reaction in the scalp not adequately protected by hypoxia.
Whether the brain could tolerate the reaction to wholesale and rapid death of tumour cells is doubtful, and clearly much more experimental work in animals having intracranial tumours would be required before such a method could even be contemplated in man. Chemical radiosensitization: The possibilities of enhancing the response to irradiation by simultaneous administration of chemical agents may offer the greatest future for radiotherapy; but the clinical effect of the agents now available is slight. Nevertheless, a number of purine and pyrimidine analogues can be incorporated in the DNA of cells (Djordjevic & Szybalski 1960) with increase in their radiosensitivity. The effect of 5-bromouracil deoxyriboside (BUDR) and 5-bromodeoxycytidine (BCDR) administered into the afferent vascular supply of a tumour is being investigated by Bagshaw & Kaplan(1962) and Bagshaw (1963) . For glioblastomata the intracarotid infusion of such substances may well augment the effect of radiation, but can hardly deal with the dominant problems of spontaneous necrosis and cell anoxia.
To return from conjecture to the immediate clinical problem of what present-day radiotherapy can offer in the treatment of gliomata: it is clear that the limiting factor lies in the vulnerability of normal brain to irradiation, rather than in the newest physical armamentarium. Within these dosage limitations, the radiosensitivity of astrocytomata increases with tumour anaplasia up to grade 3. While long-term survival is commonest in the highly differentiated tumours, those of grade 3 show the most remarkable clinical response, which may be maintained to give an average survival of about four years. Their response stimulates endeavour for improvement in grade 4 tumours where, despite occasional transient success,the results are still poor. Youth is the most favourable factor in survival, while advancing years, extensive neurological deficit and biopsy evidence of necrotic tumour are sinister portents. These factors merit consideration in selecting patients for palliative radiotherapy, until the radiotherapeutic problems, related to the secondary changes in the pathology of glioblastoma, have by further advances been overcome.
Introduction
This paper describes an isotope scanning technique, developed at Hammersmith Hospital for the localization of brain tumours, which has been in use for twenty-one months: the results are sufficiently encouraging to warrant further development.
Ideally, a method of detection should indicate the presence of the lesion, locate its site, define its extent and indicate its nature, with minimum hazard and minimal discomfort to the patient.
Radiological procedures are claimed to be 95 % accurate in indicating the presence ofa tumour and locating its site, but some believe that they are less satisfactory in respect of the other requirements. Thus there is scope for new methods of investigation. When a full clinical assessment can be made of the value of the radioisotope technique, it may prove to be of use as an ancillary to the conventional procedures with less risk than some of them Table I Differential uptake of radioactive contrast material (sodium arsenate labelled with arsenic-74) relative to normal brain (after Mealey et al., 1959) Meningiomata 17 :1 Glioblastomata 7 :1 Metastases 6 1 Astrocytomata S :1 and of comparable usefulness. It may have particular value for localization of tumours in certain. sites. Radioisotope techniques are possible because some substances, such as phosphorus, potassium, arsenic, and some dyes or proteins, occur in a higher concentration in brain tumours than in normal brain tissue. The concentration relative to normal brain shows a considerable range for a given tumour type and appears to depend somewhat less on the contrast material used; it also depends on the time after injection of the material. Typical values are shown in Table 1 . Meningiomata are the most favourable but the average value for glioblastomata is 7 :1 and for astrocytomata 5: 1. It is not known whether the effect is due to a breakdown of the normal blood-brain barrier which exists for the arsenate ion (and albumin molecule), or to enhanced intracellular uptake; but in the gliomata, the breakdown of the barrier is probably predominant.
The problem therefore is to find the best method of visualizing the distribution of radioactivity within the head and also a method which will most clearly differentiate between the normal brain levels of radioactivity and the slightly higher level for the region of the head containing the tumour volume. All the radioactive methods use radioisotopes which emit y rays during their radioactive decay; these rays pass through the head and can be detected by scintillation counters placed externally. These counters can be designed to accept radiation only from a small area, for example, an area of 2 cm diameter, by using a collimator which is usually made of lead. When the counter is held over the area above the tumour the number of y rays registered per second, or the count-rate, is somewhat greater than the countrate over surrounding areas. The increase will not be as large as the concentration ratios shown in Table 1 because the normal brain tissue between the tumour and the counter will have a masking effect.
The Technique with Radio-arsenic The early workers (Moore 1953 , Belcher et al. 1952 ) used di-iodofluorescein labelled with radioactive iodine which was not found to be useful and the materials which are in use today at other centres are radioactive arsenic (Sweet et al. 1959) 
